Helios, the ship’s AI, announced:
Triple‑negative breast cancer (TNBC) accounts for ~15‑20 % of all breast cancers and is characterized by an aggressive clinical course, early metastasis, and a paucity of targeted therapies (1). Genomic analyses have highlighted the phosphatidylinositol‑3‑kinase (PI3K)/AKT/mTOR axis as a central driver of proliferation, survival, and chemoresistance in TNBC (2,3). While several pan‑class I PI3K inhibitors have entered clinical testing, dose‑limiting toxicities—particularly hyperglycemia, rash, and immune suppression—have limited their therapeutic window (4). Consequently, there is a critical need for next‑generation PI3K inhibitors with improved selectivity, oral bioavailability, and tumor‑specific activity. MEYD-773
5 × 10⁶ MDA‑MB‑231 cells (luciferase‑expressing) were injected into the fourth mammary fat pad of 6‑week‑old female athymic nude mice (n = 10/group). Treatment started when tumors reached ~100 mm³: vehicle (0.5 % methylcellulose), MEYD‑773 (20 mg kg⁻¹ p.o. qd), paclitaxel (10 mg kg⁻¹ i.p. weekly), or combination. Tumor volume was measured twice weekly by calipers and bioluminescence imaging. Consequently, there is a critical need for next‑generation
The film features actress and was directed by Take-d . It is part of the "Meidi" series, which often focuses on specific character-driven narratives. Production Details Release Date : October 5, 2021 Lead Performer : Tsukasa Aoi Studio/Label : Meidi (MEYD) Runtime : Approximately 120 minutes About the Lead Performer qd), paclitaxel (10 mg kg⁻¹ i